Compare IIIN & OFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IIIN | OFIX |
|---|---|---|
| Founded | 1953 | 1987 |
| Country | United States | United States |
| Employees | 1007 | N/A |
| Industry | Steel/Iron Ore | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 574.2M | 481.0M |
| IPO Year | 1994 | 1998 |
| Metric | IIIN | OFIX |
|---|---|---|
| Price | $29.53 | $9.27 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $17.25 |
| AVG Volume (30 Days) | 104.0K | ★ 295.5K |
| Earning Date | 04-16-2026 | 05-05-2026 |
| Dividend Yield | ★ 4.37% | N/A |
| EPS Growth | ★ 112.12 | 29.39 |
| EPS | ★ 1.12 | N/A |
| Revenue | $647,706,000.00 | ★ $822,312,000.00 |
| Revenue This Year | $14.20 | $6.13 |
| Revenue Next Year | $6.82 | $6.22 |
| P/E Ratio | $26.87 | ★ N/A |
| Revenue Growth | ★ 22.39 | 2.85 |
| 52 Week Low | $24.35 | $8.50 |
| 52 Week High | $39.22 | $16.99 |
| Indicator | IIIN | OFIX |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 39.08 |
| Support Level | N/A | N/A |
| Resistance Level | N/A | $10.66 |
| Average True Range (ATR) | 0.00 | 0.32 |
| MACD | 0.00 | 0.04 |
| Stochastic Oscillator | 0.00 | 41.00 |
Insteel Industries Inc produces and sells prestressed concrete strand (PC strand) and welded wire reinforcement (WWR). PC strand, a high-strength seven-wire cable, is used to strengthen precast concrete in structures like bridges, parking decks, and buildings, enabling longer spans and slimmer designs. WWR includes engineered structural mesh for primary reinforcement, concrete pipe reinforcement for drainage and sewage systems, and standard WWR for crack control in residential and light commercial construction. The company serves markets in the United States and internationally, with the majority of revenue generated in the United States.
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.